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The slide agglutination test MRSA-Screen (Denka Seiken Co., Niigata, Japan) was compared with the mecA
PCR (“gold standard”) for the detection of methicillin resistance in Staphylococcus aureus. The MRSA-Screen
test detected the penicillin-binding protein 2a (PBP2a) antigen in 87 of 90 genetically diverse methicillin-
resistant S. aureus (MRSA) stock culture strains, leading to a sensitivity of 97%. The three discrepant MRSA
strains displayed positive results only after induction of the mecA gene by exposure to methicillin. Both mecA
PCR and MRSA-Screen displayed negative results among the methicillin-susceptible S. aureus strains (n 5
106), as well as for Micrococcus spp. (n 5 10), members of the family Enterobacteriaceae (n 5 10), Streptococcus
pneumoniae (n 5 10), and Enterococcus spp. (n 5 10) (specificity 5 100%). Producing the same PBP2a antigen,
all 10 methicillin-resistant Staphylococcus epidermidis strains score positived in both the latex test and the mecA
PCR. Consequently, the MRSA-Screen test should be applied only after identification of the MRSA strain to
the species level to rule out coagulase-negative staphylococci. In conclusion, due to excellent specificity and
sensitivity the MRSA-Screen latex test has the potential to be successfully used for routine applications in the
microbiology laboratory.
In most routine microbiological settings, the detection of
methicillin resistance among Staphylococcus aureus isolates is
based on phenotypic assays. Genetic confirmation of positive
findings based on the detection of the mecA gene (4) is per-
formed in reference laboratories only, as these techniques are
not yet generally available. Methicillin resistance in staphylo-
cocci is mediated by the mecA gene, encoding the penicillin-
binding protein 2a (PBP2a), which has a reduced affinity for
beta-lactam antibiotics. Denka Seiken has developed a simple
latex agglutination assay for the detection of methicillin resis-
tance, which makes use of a specific monoclonal antibody di-
rected toward the PBP2a antigen (5). In order to get insight
into the sensitivity of the assay, 90 genetically unrelated me-
thicillin-resistant S. aureus (MRSA) strains were included as
well as 106 epidemiologically unrelated methicillin-susceptible
S. aureus (MSSA) strains to control the specificity of the assay.
In order to test the extent of cross-reactivity of the MRSA-
Screen assay, other species were also included: 10 methicillin-
resistant Staphylococcus epidermidis (MRSE) strains and 10
isolates each of species of the family Enterobacteriaceae, Mi-
crococcus spp., Enterococcus spp., and Streptococcus pneu-
moniae (Table 1).
S. aureus strains were identified by the AccuProbe S. aureus
culture identification test (Gen-Probe, Inc., San Diego, Calif.),
performed in accordance with the manufacturer’s protocol.
Methicillin resistance of all S. aureus (MRSA and MSSA) and
S. epidermidis (MRSE) strains was analyzed by means of the
disk diffusion test in accordance with National Committee for
Clinical Laboratory Standards guidelines (6), and the mecA
gene was detected by PCR as the “gold standard” (4). Coag-
ulase-negative staphylococci were identified as S. epidermidis
by Staphaurex (Murex Biotech Ltd., Dartford, United King-
dom) and API-Staph (bioMe´rieux, Marcy l’Etoile, France).
The complete panel of strains (Table 1) was tested with
MRSA-Screen, and the test was performed in accordance with
the manufacturer’s protocol. In short, a loopful of bacterial
cells was suspended in 200 ml of extraction reagent 1 and
subsequently lysed by boiling for 3 min. After cooling to room
temperature, 50 ml of extraction reagent 2 was added to 200 ml
of the lysate and samples were mixed well. After 5 min of
centrifugation (1,500 3 g), 50 ml of the supernatant was used
for testing agglutination with sensitized latex particles (1 drop)
and another 50 ml of the supernatant was used for testing with
the control latex particles (1 drop). The test slides were mixed
by rotating them for 3 min, after which agglutination was as-
sessed visually. S. aureus ATCC 29213 was used as a negative
control in both the mecA PCR and the MRSA-Screen test. A
mecA-positive clinical isolate was used as a positive control
strain.
The results are summarized in Table 2. For all 90 genetically
diverse MRSA strains consisting of six different mecA types
(2), the presence of the mecA gene was reconfirmed with PCR.
As MRSA-Screen detects the PBP2a antigen in 87 of 90
MRSA strains, the sensitivity is 97%. Repeated testing after
multiple subculturing did not reconcile the results for the three
initial agglutination-negative, mecA-positive S. aureus isolates.
These discrepancies are probably due to the suppression of
mecA gene transcription (3). In order to bypass this problem,
the three isolates were again incubated overnight in the pres-
ence of a disk containing 5 mg of methicillin. The MRSA-
Screen assay was repeated with colonies taken within the zone
of inhibition or at the border of the inhibition zone. All three
isolates became positive, whereas the control, i.e., colonies
taken from the same culture plate but not in the vicinity of the
methicillin disk, remained negative. These findings actually
indicate that the sensitivity of the assay can be improved by
performing the agglutination assay with isolates previously ex-
posed to methicillin. None of the 106 genetically diverse MSSA
strains demonstrated positive results with MRSA-Screen or
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the mecA PCR, directing the specificity to 100%. The Enter-
obacteriaceae strains, S. pneumoniae, Enterococcus spp., and
Micrococcus spp. were identified with Microscan (Dade Beh-
ring, Leusden, The Netherlands), optochin disk diffusion (Ox-
oid, Basingstoke, United Kingdom), Vitek (bioMe´rieux), and
API-Staph (bioMe´rieux), respectively. Among these genera,
no false-positive results could be detected, ruling out the pres-
ence of cross-reacting antigens. Since the genetic mechanism
of methicillin resistance in coagulase-negative staphylococci is
identical to that in S. aureus (1), all MRSE strains (n 5 10)
displayed positive results in both mecA PCR and the MRSA-
Screen test.
In our opinion, the assay should be applied in a routine
setting by using the following consecutive steps. After isolation
of a suspect MRSA strain, it first needs to be identified to the
species level to exclude coagulase-negative staphylococci. Sec-
ond, the potential MRSA strain is subjected to the MRSA-
Screen test. In the event of a positive result, the identification
is definitely MRSA. If a negative result is found, the assay has
to be repeated after the strain has been exposed to methicillin
in order to induce possible methicillin resistance. If the MRSA
strain is then positive, MRSA has been identified. In the event
of a negative result, the mecA PCR should be used as the final
and conclusive confirmation assay.
In conclusion, the MRSA-Screen latex test has the potential
for the detection of MRSA in a routine microbiology setting as
it combines high speed and excellent specificity and sensitivity
with limited requirements for special equipment or skilled
personnel.
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TABLE 1. Characterization of the strain collections used in this study
Species No. of strains Origin Reference(s)
MRSA 90 Geographically and temporally diverse strains (n 5 40) 2, 7
Community-acquired strains from New York, N.Y., hospital (n 5 26) 8
Strains from outbreak clusters in EMCRa (n 5 24)
MSSA 106 Primary blood culture isolates from EMCR (n 5 91)
Geographically and temporally diverse strains (n 5 15) 2, 7
MRSE 10 Isolates from hematology department of EMCR
Enterobacteriaceae member 10 Primary clinical isolates from blood cultures at EMCR
S. pneumoniae 10 Primary clinical isolates from blood cultures at EMCR
Enterococcus sp. 10 Primary clinical isolates from blood cultures at EMCR
Micrococcus 10 Primary clinical isolates from blood cultures at EMCR
a EMCR, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
TABLE 2. Results obtained with diagnostic tests on
diverse strain collectionsa
Organism No. ofisolates
No. (%) of isolates positive by:
AccuProbe mecA PCR MRSA-Screen
MRSA 90 90 (100) 90 (100) 87 (97)
MSSA 106 106 (100) 0 (0) 0 (0)
MRSE 10 ND 10 (100) 10 (100)
a Micrococcus spp., S. pneumoniae, Enterococcus spp., and Enterobacteriaceae
strains displayed no agglutination test results with the MRSA-Screen assay. The
other diagnostic tests were not done for these strains. ND, not done.
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